Research project

A DAVIES - A Phase 1b/11 combination of ACP-196 with Rituximiab, Cyclophosphamide, doxorubicin, Vincristine and Prenisolone (R-CHOP) for patients with Diffused B-cell Lymphoma (DLBCL) - "ACCEPT" - ACP-196 - ACERTA

Staff

Lead researchers

Professor Gareth Griffiths

Director SCTU & Prof of Clinical Trials
Research interests
  • Gareth Griffiths is Professor of Clinical Trials and directs our Southampton Clinical Trials …
  • His works spans the different phases of clinical trials, from small dose finding and safety s…
  • Phase I-III clinical trials
Connect with Gareth

Collaborating research institutes, centres and groups

Research outputs